 Kevin Phelan
Concepts (113)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| TRPC Cation Channels | 5 | 2020 | 18 | 2.380 |
Why?
| | Seizures | 4 | 2015 | 195 | 1.840 |
Why?
| | Status Epilepticus | 4 | 2020 | 38 | 1.540 |
Why?
| | Neurons | 4 | 2019 | 479 | 1.170 |
Why?
| | Cadaver | 3 | 2021 | 121 | 0.970 |
Why?
| | Embalming | 2 | 2021 | 10 | 0.970 |
Why?
| | Manikins | 2 | 2021 | 35 | 0.910 |
Why?
| | Urinary Catheters | 1 | 2021 | 6 | 0.890 |
Why?
| | Pro-Opiomelanocortin | 2 | 2019 | 10 | 0.840 |
Why?
| | Melanocortins | 1 | 2019 | 3 | 0.790 |
Why?
| | Appetite | 1 | 2019 | 19 | 0.780 |
Why?
| | Radiology, Interventional | 1 | 2018 | 34 | 0.720 |
Why?
| | Ultrasonography, Interventional | 2 | 2018 | 147 | 0.720 |
Why?
| | Theta Rhythm | 1 | 2016 | 14 | 0.670 |
Why?
| | Pilocarpine | 5 | 2020 | 22 | 0.640 |
Why?
| | Brain | 6 | 2020 | 1429 | 0.570 |
Why?
| | Behavior, Animal | 1 | 2015 | 222 | 0.540 |
Why?
| | Mice | 11 | 2021 | 6254 | 0.500 |
Why?
| | CA1 Region, Hippocampal | 1 | 2012 | 28 | 0.500 |
Why?
| | Mice, Knockout | 5 | 2020 | 986 | 0.470 |
Why?
| | Signal Transduction | 1 | 2019 | 1812 | 0.440 |
Why?
| | Electroencephalography | 4 | 2020 | 349 | 0.430 |
Why?
| | Microglia | 3 | 2021 | 130 | 0.430 |
Why?
| | Ethanol | 4 | 2015 | 322 | 0.420 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 2019 | 9 | 0.390 |
Why?
| | Animals | 15 | 2021 | 14412 | 0.390 |
Why?
| | Disease Models, Animal | 5 | 2020 | 1659 | 0.350 |
Why?
| | Mice, Inbred C57BL | 7 | 2021 | 2029 | 0.310 |
Why?
| | Receptors, Metabotropic Glutamate | 2 | 2014 | 13 | 0.270 |
Why?
| | Long-Term Potentiation | 2 | 2014 | 26 | 0.270 |
Why?
| | Cerebellum | 3 | 2021 | 135 | 0.270 |
Why?
| | Immunity | 2 | 2013 | 36 | 0.260 |
Why?
| | Central Nervous System Depressants | 2 | 2013 | 80 | 0.250 |
Why?
| | Wasting Syndrome | 1 | 2022 | 7 | 0.250 |
Why?
| | Growth Disorders | 1 | 2022 | 67 | 0.240 |
Why?
| | Nursing Education Research | 1 | 2021 | 39 | 0.220 |
Why?
| | alpha-MSH | 1 | 2019 | 17 | 0.200 |
Why?
| | Receptor, Melanocortin, Type 4 | 1 | 2019 | 17 | 0.190 |
Why?
| | Anti-Obesity Agents | 1 | 2019 | 24 | 0.190 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 38 | 0.190 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2020 | 156 | 0.190 |
Why?
| | Aging | 3 | 2013 | 759 | 0.180 |
Why?
| | Nephrology | 1 | 2018 | 17 | 0.180 |
Why?
| | Phantoms, Imaging | 1 | 2018 | 115 | 0.180 |
Why?
| | Immunity, Cellular | 2 | 2015 | 85 | 0.180 |
Why?
| | Peptides | 1 | 2019 | 280 | 0.170 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2013 | 216 | 0.170 |
Why?
| | Repressor Proteins | 1 | 2019 | 170 | 0.170 |
Why?
| | Analysis of Variance | 2 | 2016 | 664 | 0.170 |
Why?
| | Muscarinic Agonists | 1 | 2016 | 12 | 0.170 |
Why?
| | Spectrum Analysis | 1 | 2016 | 65 | 0.170 |
Why?
| | Thiazolidinediones | 2 | 2015 | 104 | 0.170 |
Why?
| | Diet, High-Fat | 1 | 2019 | 208 | 0.160 |
Why?
| | Reaction Time | 1 | 2016 | 241 | 0.150 |
Why?
| | CA3 Region, Hippocampal | 1 | 2014 | 4 | 0.140 |
Why?
| | Pyramidal Cells | 1 | 2014 | 20 | 0.140 |
Why?
| | Electric Stimulation | 1 | 2014 | 84 | 0.140 |
Why?
| | Clinical Competence | 1 | 2018 | 435 | 0.140 |
Why?
| | Models, Neurological | 1 | 2014 | 74 | 0.140 |
Why?
| | Action Potentials | 1 | 2014 | 128 | 0.130 |
Why?
| | Spatial Behavior | 1 | 2012 | 13 | 0.130 |
Why?
| | Obesity | 2 | 2019 | 1125 | 0.130 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 52 | 0.130 |
Why?
| | Neuroimmunomodulation | 1 | 2012 | 14 | 0.120 |
Why?
| | Kidney | 1 | 2018 | 763 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1556 | 0.120 |
Why?
| | Humans | 6 | 2022 | 51226 | 0.120 |
Why?
| | Microscopy, Electron | 1 | 2011 | 94 | 0.120 |
Why?
| | Immunohistochemistry | 2 | 2013 | 1135 | 0.120 |
Why?
| | Cell Death | 1 | 2012 | 234 | 0.120 |
Why?
| | PPAR gamma | 1 | 2011 | 76 | 0.110 |
Why?
| | Time Factors | 1 | 2016 | 3392 | 0.090 |
Why?
| | Male | 5 | 2020 | 27647 | 0.090 |
Why?
| | Pregnancy | 4 | 2021 | 2461 | 0.090 |
Why?
| | Cerebral Cortex | 3 | 2015 | 257 | 0.090 |
Why?
| | Hippocampus | 3 | 2015 | 244 | 0.090 |
Why?
| | Receptors, Peptide | 1 | 2005 | 9 | 0.080 |
Why?
| | Thalamic Nuclei | 1 | 2005 | 10 | 0.080 |
Why?
| | Chemokine CCL2 | 2 | 2013 | 74 | 0.060 |
Why?
| | DNA, Complementary | 2 | 2013 | 145 | 0.060 |
Why?
| | RNA | 2 | 2013 | 175 | 0.060 |
Why?
| | Gene Expression | 2 | 2021 | 708 | 0.060 |
Why?
| | Chemokine CX3CL1 | 1 | 2021 | 8 | 0.060 |
Why?
| | Pentylenetetrazole | 1 | 2020 | 6 | 0.050 |
Why?
| | Inflammasomes | 1 | 2021 | 62 | 0.050 |
Why?
| | Prevalence | 1 | 2022 | 970 | 0.050 |
Why?
| | Cerebrovascular Circulation | 1 | 2020 | 161 | 0.050 |
Why?
| | Female | 5 | 2021 | 28342 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2020 | 722 | 0.040 |
Why?
| | Cytokines | 1 | 2021 | 683 | 0.040 |
Why?
| | Self Efficacy | 1 | 2018 | 139 | 0.040 |
Why?
| | Fellowships and Scholarships | 1 | 2018 | 117 | 0.040 |
Why?
| | Biopsy | 1 | 2018 | 690 | 0.040 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2013 | 40 | 0.030 |
Why?
| | Infant | 1 | 2022 | 3600 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2018 | 546 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2013 | 307 | 0.030 |
Why?
| | Astrocytes | 1 | 2013 | 150 | 0.030 |
Why?
| | Prostaglandin D2 | 1 | 2011 | 23 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 430 | 0.030 |
Why?
| | Fetus | 1 | 2012 | 229 | 0.030 |
Why?
| | Cell Count | 1 | 2011 | 193 | 0.030 |
Why?
| | Child | 1 | 2022 | 6663 | 0.030 |
Why?
| | Cell Survival | 1 | 2011 | 687 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2011 | 1828 | 0.020 |
Why?
| | Electrophysiology | 1 | 2005 | 70 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2005 | 45 | 0.020 |
Why?
| | Patch-Clamp Techniques | 1 | 2005 | 141 | 0.020 |
Why?
| | Ligands | 1 | 2005 | 248 | 0.020 |
Why?
| | Insulin | 1 | 2005 | 518 | 0.010 |
Why?
| | Proteins | 1 | 2005 | 393 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2005 | 1254 | 0.010 |
Why?
| | Rats | 1 | 2005 | 3493 | 0.010 |
Why?
|
|
Phelan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|